HCAT

Health Catalyst, Inc. (HCAT) ESG Analysis Analysis (2026)

Invetso Score: 6.9/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 6.4 (Moderate)

HCAT appears mid-pack environmentally because its disclosed R&D intensity supports product innovation, yet peers in healthcare technology often show similar spending levels.

The company’s capital allocation is not clearly disadvantaged on environmental grounds, but the provided metrics do not evidence a peer-leading decarbonization or resource-efficiency profile.

No direct emissions, energy, or waste disclosures were provided, limiting evidence of a structural environmental advantage versus peers with more mature sustainability reporting.

Overall environmental positioning is moderate because available data suggests operational discipline, but not enough peer-differentiated environmental leadership to justify a stronger score.

Social

Score:

HCAT’s relatively high R&D-to-revenue ratio indicates sustained investment in product development, which can support patient-facing quality and service reliability versus peers.

Stock-based compensation remains moderate, suggesting employee incentives are meaningful without appearing excessive relative to peers, which can help retention and execution stability.

The absence of disclosed labor, safety, or customer-incident metrics prevents a top-tier social assessment, but no evidence indicates a peer-level social weakness.

Overall social positioning is strong because the available indicators point to workforce and product-investment discipline that compares favorably with many healthcare peers.

Governance

Score:

HCAT’s stock-based compensation at roughly 6.0% of revenue is manageable, but it still creates dilution pressure that is often lower at stronger-governed peers.

A debt-to-equity ratio above 1.6 suggests leverage is meaningful, which can constrain governance flexibility relative to peers with more conservative balance sheets.

Net debt to EBITDA is negative, indicating net cash, which partially offsets leverage concerns and supports a more balanced governance profile than highly indebted peers.

Overall governance is moderate because capital discipline looks acceptable, but leverage and equity compensation keep the company short of stronger peer governance standards.

Overall Score

Score:

HCAT’s ESG profile is broadly middle-tier versus peers, with stronger social characteristics offset by only moderate environmental and governance positioning.

Score Driver: Social Investment Discipline Is The Clearest Relative Strength, While Leverage And Limited Environmental Disclosure Cap The Overall Score.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Health Catalyst, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →